BioInItaly Newsletter

La vetrina del biotech italiano all’estero
  • 03 mag, 2013
    Sommario
    EryDel SpA Announces EMA Orphan Drug Designation for EryDex for the treatment of Ataxia Telangiectasia                                                               
    MolMed: Long-term data presented at ASCO confirm prolonged survival times of patients with acute leukaemia treated with TK cell therapy
    Nicox Strengthens Ophthalmic Portfolio with Immco Diagnostics' Proprietary Test in the Dry Eye Market
  • 05 apr, 2013
    Sommario
    Presented the "Italian Biotechnology Report 2013" by Assobiotec and Ernst & Young
    EryDel announces US IND approval for EryDex
    Pre-clinical results on naproxcinod in models of muscular dystrophy presented at MDA Scientific Conference
  • 01 mar, 2013
    Sommario
    Turin will hosts Bio Europe Spring 2014
    Nicox strengthens its European and International Operations team and expands its product pipeline
    Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology Sardegna Ricerche will hold a workshop entitled "From Nanomedicine to Brain Imaging. New Frontiers in Nanobiotechnology"
  • 01 feb, 2013
    Sommario
    A new antibiotic class discovered at NAICONS awarded a grant by NIH
    Meeting “Pancreatic Cancer”- BIOUNIVERSA
  • 31 gen, 2013
    Sommario
    Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate Licensed from Nicox
    Aptuit signs agreements with Alios BioPharma and Aegerion Pharmaceuticals
    Diagnosis of rheumatoid arthritis: a new kit from the collaboration between Toscana Biomarkers and AMAR Immunodiagnostics soon on the Indian market
    Aptalis Pharma, Inc. Announces Results of Phase 3 Studies of Aeroquin(TM) (Levofloxacin Solution for Inhalation) Among Patients With Cystic Fibrosis and Chronic Lung Infection
    Dako enters collaboration with Eli Lilly and Company for development of companion diagnostics
    Boehringer Ingelheim and Eli Lilly and Company announce positive top-line pivotal Phase III data results for empagliflozin
    Axxam announces the appointment of Dr. Doris Hafenbradl as Vice-President, Discovery Services
  • 03 dic, 2012
    Sommario
    Eporgen’s portfolio company Genovax sells GX301, its clinical-stage therapeutic vaccine for the treatment of various types of cancer, to Mediolanum Farmaceutici
    TOP srl announces a collaboration with Charles River Laboratories International for the marketing and sales in North America (USA and Canada) of its products.
  • 05 nov, 2012
    Sommario
    Collaboration agreement between Telethon Foundation and Rare Partners
    Development and validation of a new kit for the detection of deletions in the AFZ locus associated with male infertility, based on Reverse Line Blot Technique
    The European Institute of Oncology aims to develop a localized and more tolerable radiotherapy for breast cancer
    Cell Therapeutics’ Unique Orally Available, Multi-Kinase Inhibitor CT-1578
    ABRAXANE the first Nano-chemo target therapy already approved for the treatment of metastatic breast cancer  meets Primary Endpoint of Progression-Free Survival in Phase III Chemotherapy-Naïve Metastatic Melanoma Study
    ViroStatics AV-HALT Phase 2a Study in HIV/AIDS Paper Published in PLoS ONE
    Nicox launches AdenoPlus(TM) in the United States
  • 03 ott, 2012
    Sommario
    AIFA - ISS – Assobiotec sign an agreement to stimulate the clinical trials in the field of biotechnology in Italy
    Servier concludes a collaboration and license agreement with EOS for its antitumor drug E-3810
    Cell Therapeutics Announces European Launch of Pixuvri® for Treatment of Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphoma
    Cell Therapeutics OPAXIO Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
    Adienne moves offices
  • 03 lug, 2012
    Sommario
    The European Patent Office grants MolMed a new patent on its anticancer drug NGR-hTNF
    Cell Therapeutics Completes Acquisition of Pacritinib a Highly Selective JAK2 Inhibitor
    Mediapharma established in Chieti
    NicOx signs worldwide licensing agreement with Rapid Pathogen Screening, Inc. for ophthalmic diagnostics
    Medi Service: signal detection
    Toscana Biomarkers Coordinator of GAPAID project, ranked 12th in "Research for SMEs" call of the 7° Framework Programme
    New initiatives from Fondazione Filarete
    The Distretto Toscano Scienze della Vita/Tuscany Life Science Cluster is looking for a Temporary Manager
  • 01 giu, 2012
    Sommario
    A strategic alliance on anti-cancer drugs between NERVIANO and IEO
    Cell Therapeutics’ Pixuvri Approved in European Union as monotherapy to treat adult patients with multiply relapsed or refractory aggressive Non-Hodgkin B-Cell Lymphomas
    Cell Therapeutics enters into agreement to acquire Pacritinib, a Novel Highly Selective JAK2 Inhibitor Phase 3 Candidate for Myelofibrosis
    New England Journal of Medicine reports on three Phase III Revlimid (lenalidomide) trials in patients with newly diagnosed multiple myeloma
  • 02 mag, 2012
    Sommario
    Abcodia and Biouniversa announce collaboration on BAG3 biomarker for the early detection of pancreatic cancer
    A collaboration between Heinz and IEO gives birth to a new generation of infant food
    NicOx appoints Philippe Masquida EVP, Managing Director of European Operations
  • 01 apr, 2012
    Sommario
    NicOx, Bausch + Lomb Glaucoma Candidate BOL-303259-X Meets Primary Endpoint in Phase 2b Study
    NicOx enters into option agreement to acquire Altacor as a first step towards building an international ophthalmology business
    Axxam receives EUR 2.3 million grant from the Italian Ministry of Research to support innovative drug discovery programs
    Aptuit Verona invests on a preclinical cardiac safety panel
    BioInItaly 2012: The Italian Biotech Investment Forum, where biotech meets investors